allodynia from glp-1 is being reported with medications It is a heightened sensitivity to touch that can feel like pain. We are seeing it more at higher doses The important point is that Advances in GLP-1 receptor agonists
Description
According to the American Academy of Ophthalmology, U.S
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine , vol
If reflux is the bigger issue, managing acid reflux on GLP-1 is a useful companion read
At the same time, neurotransmitters such as dopamine, serotonin, and norepinephrine finely tune taste responsiveness from individual taste buds to cortical reward pathways, ensuring adaptive eating behaviors (1, 2)
It will be usefull to better underdstand the best exit strategy from GLP1 RA and the physiopathology underlying the MOA during entry treatment phase also, respect physiology before treating the physiopatlogy trigger point, it is not a matter of AE and body weight gain may be consider an Expected AE
